CK
Chad Kerr
View Chad's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Jul 2022 - Present · 2 years and 5 months
N/A
Dec 2022 - Present · 2 years
N/A
Jul 2022 - Oct 2022 · 3 months
N/A
May 2020 - May 2022 · 2 years
Company Details
51-200 Employees
emnify is the leading cloud building block for cellular communications in the IoT stack, connecting millions of IoT devices globally – from electric vehicles to energy meters, alarm systems to GPS trackers, thermometers to health wearables. The emnify API and SIM technology connect and secure any kind of IoT deployment to its application back-end. emnify’s cloud-native integrations and no-code workflows ensure seamless lifecycle scalability for deployments of all sizes – from local start-up to global enterprise. The emnify IoT SuperNetwork is the largest globally distributed mobile cloud core network of its kind, supporting local network access (2G – 5G, LTE-M, NB-IoT) in over 180 countries from more than 25 cloud regions – and counting. emnify’s solution is built on partnerships with the leading hyperscaler cloud service providers, system integrators and hundreds of radio network operators worldwide. Founded in 2014, emnify was the first to transform cellular IoT connectivity into an easy-to-consume cloud resource – trusted today by thousands of the world’s most innovative companies. To learn more about emnify, please visit www.emnify.com
Year Founded
2014
Social Media
LinkedinFacebookTwitter
Industry
Telecommunications, Management services, Services to businesses, Business Services
HQ Location
Charlottenstraße 4 Berlin, Berlin 10969, DE
Keywords
The Internet of Things - IoTMachine-2-Machine M2MSaaS Software as a ServiceIaaS Infrastructure as a ServiceNFVSDNHSS HLR GGSN PGWtelecommunicationcloudEngineering
Discover More About Cleveland Clinic

Find verified contacts of Chad Kerr in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.